S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
NYSE:BXC

BlueLinx (BXC) Stock Price, News & Analysis

$110.06
-3.71 (-3.26%)
(As of 04/17/2024 ET)
Today's Range
$109.59
$114.37
50-Day Range
$110.06
$131.10
52-Week Range
$66.58
$132.67
Volume
80,571 shs
Average Volume
72,783 shs
Market Capitalization
$952.02 million
P/E Ratio
20.88
Dividend Yield
N/A
Price Target
$144.00

BlueLinx MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
30.8% Upside
$144.00 Price Target
Short Interest
Healthy
2.53% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.88mentions of BlueLinx in the last 14 days
Based on 4 Articles This Week
Insider Trading
Selling Shares
$1 M Sold Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.33 out of 5 stars

Construction Sector

47th out of 98 stocks

Lumber, Plywood, & Millwork Industry

1st out of 1 stocks

BXC stock logo

About BlueLinx Stock (NYSE:BXC)

BlueLinx Holdings Inc., together with its subsidiaries, engages in the distribution of residential and commercial building products in the United States. It distributes specialty products, including engineered wood, siding, millwork, outdoor living, specialty lumber and panels, and industrial products; and structural products, such as lumber, plywood, oriented strand boards, rebars and remesh, as well as other wood products that are used for structural support in construction projects. It also provides various value-added services and solutions to customers and suppliers. The company serves national home centers, pro dealers, cooperatives, specialty distributors, regional and local dealers, and industrial manufacturers. BlueLinx Holdings Inc. was incorporated in 2004 and is headquartered in Marietta, Georgia.

BXC Stock Price History

BXC Stock News Headlines

The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
BlueLinx Announces Executive Leadership Changes
BXC BlueLinx Holdings Inc.
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
BXC Apr 2024 150.000 call
BXC Aug 2024 80.000 put
BXC Mar 2024 80.000 put
Recap: BlueLinx Hldgs Q4 Earnings
BXC May 2024 120.000 call
BlueLinx Holdings Inc. (BXC)
BXC May 2024 90.000 put
Here's what Wall Street expects from BlueLinx's earnings
BlueLinx Hldgs's Earnings Outlook
BXC Mar 2024 60.000 put
See More Headlines
Receive BXC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BlueLinx and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/20/2024
Today
4/17/2024
Next Earnings (Estimated)
5/07/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Lumber, plywood, & millwork
Sub-Industry
Trading Companies & Distributors
CUSIP
09624H10
Employees
2,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$144.00
High Stock Price Target
$144.00
Low Stock Price Target
$144.00
Potential Upside/Downside
+30.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$48.54 million
Pretax Margin
2.61%

Debt

Sales & Book Value

Annual Sales
$3.14 billion
Cash Flow
$13.05 per share
Book Value
$72.35 per share

Miscellaneous

Free Float
8,261,000
Market Cap
$951.50 million
Optionable
Optionable
Beta
1.90
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

BXC Stock Analysis - Frequently Asked Questions

Should I buy or sell BlueLinx stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for BlueLinx in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" BXC shares.
View BXC analyst ratings
or view top-rated stocks.

What is BlueLinx's stock price target for 2024?

1 brokerages have issued 12-month price objectives for BlueLinx's shares. Their BXC share price targets range from $144.00 to $144.00. On average, they expect the company's stock price to reach $144.00 in the next twelve months. This suggests a possible upside of 30.8% from the stock's current price.
View analysts price targets for BXC
or view top-rated stocks among Wall Street analysts.

How have BXC shares performed in 2024?

BlueLinx's stock was trading at $113.31 at the beginning of 2024. Since then, BXC shares have decreased by 2.9% and is now trading at $110.06.
View the best growth stocks for 2024 here
.

Are investors shorting BlueLinx?

BlueLinx saw a drop in short interest in March. As of March 31st, there was short interest totaling 210,000 shares, a drop of 19.0% from the March 15th total of 259,400 shares. Based on an average trading volume of 72,500 shares, the short-interest ratio is presently 2.9 days. Currently, 2.5% of the company's stock are sold short.
View BlueLinx's Short Interest
.

When is BlueLinx's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024.
View our BXC earnings forecast
.

How were BlueLinx's earnings last quarter?

BlueLinx Holdings Inc. (NYSE:BXC) released its quarterly earnings results on Tuesday, February, 20th. The construction company reported $2.64 earnings per share (EPS) for the quarter. The construction company had revenue of $712.53 million for the quarter. BlueLinx had a net margin of 1.55% and a trailing twelve-month return on equity of 14.81%.

What is Mitch Lewis' approval rating as BlueLinx's CEO?

56 employees have rated BlueLinx Chief Executive Officer Mitch Lewis on Glassdoor.com. Mitch Lewis has an approval rating of 49% among the company's employees. This puts Mitch Lewis in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of BlueLinx own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BlueLinx investors own include Novavax (NVAX), Micron Technology (MU), Co-Diagnostics (CODX), Livongo Health (LVGO), Intel (INTC), Maxar Technologies (MAXR), Civeo (CVEO), BowFlex (NLS), Sorrento Therapeutics (SRNE) and Hologic (HOLX).

Who are BlueLinx's major shareholders?

BlueLinx's stock is owned by a number of retail and institutional investors. Top institutional shareholders include BTC Capital Management Inc. (0.03%). Insiders that own company stock include Carol B Yancey, Kim S Fennebresque, Mitchell B Lewis, Mitchell B Lewis and Shyam K Reddy.
View institutional ownership trends
.

How do I buy shares of BlueLinx?

Shares of BXC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:BXC) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners